If you are demanding any product or service please register as Farmavita.Net network member and publish your offer or demad.
In-Licensing and oursoucing of products is usual a way for development of winning portfolio of products. License-in is also very cost effective way of product/technology development.
Opportunities are listed according chronological order, the most recent first.
I’m a representative of Parafarm (Penza, Russia) for foreign relations. We propose unique products for osteoporosis and arthritis treatment on the basis of beekeeping product, drone brood.
Some information in English you can find here:
Some other products on the basis of beekeeping products are offered too.
We have got some patents, including WO, EP, US, for our products.
But information in English...
Farmavita.Net member has developed technology which enables development of oral dosage forms with controlled and site specific release of active pharmaceutical ingredients. Patent pending application.
Company is looking for following types of cooperation: - Out-licensing - Joint-venture and private equity partners - Collaborative product development - Consulting or contract research contracts
Description of technology: - the...
Renarthro - Smarter Choice Than Gucosamine and...
License-out offer for "Natural Compound Extracted from Citrus, Extraction Process and Pharmaceutical Use" API technology
Member of Farmavita.net offers know-how about extraction process for manufacture of Natural Compound Extracted from Citrus, Extraction Process and Pharmaceutical Use.
Technology description: The present innovation regards the description, extraction and pharmaceutical use of a natural compound present in Citrus fruit,...
A Novel Means of Greatly Extending Lifespan and Resistance to Oxidative Stress
Ten fold increase in lifespan is observed for the deletion of a single gene
The findings in C. elegans are that the deletion of a specific domain of the phosphoinositol-3-kinase (PI3K) gene results in a 10-fold increase in life span.
This pathway, and this gene, is known to limit lifespan on C. elegans and, with lesser evidence, thought to affect life span in...
Private lubricant that is composed 100% of macromolecular Aloe Vera Gel powder
This innovative product can create a large worldwide market because of its particular features.
There has never been such a perfectly natural lubricant until now. The constituent of this natural lubricant is only dried Aloe Vera Gel with no aloin. By dissolving it in water, the Aloe Vera gel powder reconstitutes an amazingly smooth gel. Owing to the...
Unique extract of fresh broccoli as the guard and stimulator of natural immunity
Member of Farmavita.Net offer license for use of registrered trade mark, results of clinical studies and other product documentation. License is binded to supply of active ingredient. Extract of broccoli is obtained by the unique method which preserves all its ingredients in their natural form found in the fresh vegetable. Contact us for more...
Innovative Topical Anti Acne Formulation
- comprising of salicylic acid and tetracycline in therapeutic doses
Acne is one of the most common dermatoses affecting 30 – 60 % of the adolescents . Member of Farmavita.Net is offering licensing, contract formulation and/or collaborative research related to innovative dermatological formulations.
Acne is one of the most common of dermatoses, affecting 30 – 60 % of...
Early stage patented NO-donating molecule
Licensing out of a novel and patented NO-donating molecule with strong inhibitory activity specifically against melanoma and breast cancer cell growth.
Synergistic formulation of antioxidants and antimycobacterial agents
The present invention pertains to a six compound pharmaceutical formulation and its process of making comprising of antituberculosis agents like Rifampicin, Isoniazid, Pyrazinamide, and Ethambutal with addition of antioxidants such as d-alpha tocopherol or tocopheryl acetate and pharmaceutically accepted salts thereof and ascorbic acid in required therapeutic quantities...
Variant of Tumor Necrosis Factor
TNF-α has been clinically proven as a tumor killing agent. M3S is a TNF-α Mutein (a variant of TNF-α) proven to have superior anti-tumor activity and safety compared to natural form.
Mechanism of action
TNF-α Mutein (a variant of TNF-α) made from amino acids substitution of TNF-α variant which shown the highest cytotoxicity among variants.
Innovatve topical for Psoriasis
We are interested in Co- development of an innovative topical formulation presented in a delivery system particularly targeted for treatment of Psoriasis and other dermatoses of hyperkeratotic nature. The formulation comprises of ingredients having anti inflammatory and a keratosolvent properties. The innovative formulation presented in a specially designed delivery system is patent potential and has superior...
Development-stage pain products
The Company seeks to divest its development-stage pain products MGX-001 (extended release morphine combined with an atypical stimulant) and MGX-002 (a follow-on opioid combined with an atypical stimulant). These products are expected to significantly reduce commonly-experienced side effects versus existing opiate therapies.
Victory has completed its first Phase II "proof of concept" trial for MGX-001 and...
Our candidate, based on the Kynurenic Acid research, is a molecule with highly protective effects in the gastrointestinal system. The substance is an analogue of the naturally occurring substance(kynurenic acid) with highly protective effects in the gastrointestinal system. The target of the molecule is mainly excitatory receptors. It may also have some influence on MS. In vivo and in vitro tests were performed on male...
Herbal extract for the relief of anxiety
We offer a food supplement in the form of tablets thateffectively relieves mild to moderate anxiety problems. The active ingredientis an herbal extract with a scientifically proven efficacy. The major advantages of the product are: efficient decrease of anxiety symptoms especially when thisis precipitated by stress or excessive work load; rapid onset of action (1-2days), no side effects, easy access...
I have two promising novel classes of anticancer drugs with first in class attributes available for in licensing.
The Non Proteolytic Proteasome Inhibitor demonstrated a Proteasome inhibition through a novel mechanism/target. This compound is currently at the lead generation stage.
POC : In-vitro cytotoxicactivity on human cancer cells
A screening platform could be discussed as well
NCE for oncology - Improved HDAC inhibitors
Ikerchem offers two promising anticancer drugs with best in class attributes available for in licensing. If you are interested in acquiring or co-developing oncology products with excellent solid tumor activity and optimum safety profile, please, read the offer below.
IKH02 is currently at the late preclinical stage and is a novel oral HDAC pan-inhibitor with amazing toxicological/safety ...
Efficacy and Safety of Poly Herbal Formulation WH-1, FAS-3 Kit and Fluconazole in Female Patients with Vaginosis/ Vaginitis
Second clinical trial report of the product WH-1 developed by Dr.V.R. Bapat for different types of vaginitis (white discharge in women) has been published in the journal of Research and Education in Indian Medicine. Member of Farmavita.Net is seeking for a strategic partnership opportunity for acquisition or...